NCT05115318
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Cannabis, +14 more
- Locations
-
- Tel-Aviv Medical Center Tel Aviv, Israel
Clinical trial condition
Neurodegenerative Diseases
Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.
9,037 public trials
1,770 recruiting studies
Neurodegenerative Diseases trial results
NCT00477659
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- Medical College of Wisconsin Milwaukee, Wisconsin, United States
Completed
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
NCT01018264
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +20 more
- Locations
-
- University of Miami Miami, Florida, United States
- University of South Florida Tampa, Florida, United States
- Emory University Atlanta, Georgia, United States
NCT01723228
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Teva Investigational Site 036 Birmingham, Alabama, United States
- Teva Investigational Site 047 Sun City, Arizona, United States
- Teva Investigational Site 004 Irvine, California, United States
- Teva Investigational Site 016 La Jolla, California, United States
NCT02674321
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
- Locations
-
- Teva Investigational Site #101 Houston, Texas, United States
Completed
A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)
NCT03571256
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
- Locations
-
- Teva Investigational Site 060-0160 Gainesville, Florida, United States
- Teva Investigational Site 060-0166 Gulf Breeze, Florida, United States
- Teva Investigational Site 060-0161 Miami, Florida, United States
- Teva Investigational Site 060-0151 Orlando, Florida, United States
NCT01897896
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
- Locations
-
- Teva Investigational Site 057 Birmingham, Alabama, United States
- Teva Investigational Site 038 Phoenix, Arizona, United States
- Teva Investigational Site 298 Fayetteville, Arkansas, United States
- Teva Investigational Site 052 Englewood, Colorado, United States
NCT03452943
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
- Locations
-
- Teva Investigational Site 046-0104 Dothan, Alabama, United States
- Teva Investigational Site 046-0117 Sun City, Arizona, United States
- Teva Investigational Site 046-0107 Rogers, Arkansas, United States
- Teva Investigational Site 046-0126 Anaheim, California, United States
NCT03840005
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, South Yorkshire, United Kingdom
- University College London Institute of Neurology London, United Kingdom
Completed
Ultrasonography of the Neuromuscular Degeneration Behavior in Amyotrophic Lateral Sclerosis
NCT03683875
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Hospital General Universitario Santa Lucia Cartagena, Murcia, Spain